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Abstract
Uterine arteriovenous malformation (AVM) is a rare condition, with few cases reported in the
literature. Despite being rare, it is a potentially life-threatening condition in women of child-
bearing age. It should be considered in the differential diagnosis of prolonged or irregular
vaginal bleeding, which, otherwise, can lead to critical complications ending up in severe
morbidity and mortality. This case series describes four cases of young Asian women aged
between 33 and 38 years who presented with irregular vaginal bleeding. Trans-abdominal
ultrasound of the pelvis showed increased vascularity with multi-directional blood flow in the
uterus. Magnetic resonance imaging (MRI) confirmed an arteriovenous malformation in all
cases. All cases remained stable through the diagnostic journey. Embolization of the
arteriovenous malformation was performed successfully in three cases and one case was
managed conservatively on hormones. Later, two of them conceived within a year and had live
births at term. The aim of reporting these cases is to share the common presentation of this
condition and our experience in making the diagnosis and treatment of such patients. Although
a few cases are reported world over, none was reported earlier from Pakistani Asian women.
Categories: Obstetrics/Gynecology, Radiology
Keywords: arterio venous malformations, embolisation, irregular vaginal bleeding ultrasound
Introduction
Uterine arteriovenous malformation is a rare, life-threatening gynecological disease with less
than 100 cases reported in the literature. It occurs as a result of abnormal and nonfunctional
communication between the branches of uterine arteries and veins without an intervening
capillary network [1-2]. Clinical presentations vary from irregular to heavy vaginal bleeding. It
contributes to about 1%-2% of all genital and intraperitoneal hemorrhage and is usually
diagnosed in women with unexplained vaginal bleeding at child-bearing age [3]. It may be
congenital or acquired [4]. Congenital presentation is rare. Acquired uterine arteriovenous
malformations occur mostly after damage to uterine tissue and are associated with conditions,
such as pregnancy, uterine surgical procedure (cesarean section, curettage) [5-6], and, less
commonly, cervical or endometrial carcinoma, infection, gestational trophoblastic disease, and
exposure to diethylstilbestrol [7]. The diagnosis is easily made by using color Doppler
ultrasonography showing a mosaic pattern and magnetic resonance imaging (MRI), which are
non-invasive techniques. Pelvic angiography is also used for its confirmation. Hysteroscopy
can also be used for diagnosis, but it is invasive [8]. The treatment of uterine arteriovenous
malformation mainly depends on the patient’s age, symptoms, desire for fertility, and site of
uterine arteriovenous malformation lesion. Treatment options include hysteroscopic resection
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of the lesion [8], laparoscopic coagulation of uterine vessels [9], selective embolization [10], and
hysterectomy [11]. The conservative approach includes medical treatment with non-steroidal
anti-inflammatory drugs (NSAIDs), methylergonovine maleate [12], danazol [13], and
gonadotropin-releasing hormone (GnRH) agonist [14], but it is associated with a high failure
rate and persistent bleeding in some cases.
This case series highlights our experience in Asian (Pakistani) women having this rare
gynecological condition at our medical center and discloses a new differential diagnosis of
irregular vaginal bleeding from this part of the world.
Case Presentation
Case 1
A 32-year-old Asian woman, gravida 7 P3+2, with previous two scars, presented with seven
weeks missed miscarriage. She underwent evacuation and was discharged in stable condition.
She presented with heavy vaginal bleeding on the 10th postoperative day. There was no
significant family history of gynecologic or genetic disease. Systemic examination was
unremarkable except for pallor. Pelvic examination revealed bulky uterus, normal adnexa, and
the os was closed with no active bleeding per vaginam. She was readmitted and the
ultrasonography showed a bulky uterus with a complex mass measuring 7x6x11 cms in the
lower part of the anterior wall of the uterus containing the multiple pools of blood and dilated
vessels with blood flow (Figure 1). The histopathology report of products of conception
revealed no trophoblastic disease. A provisional diagnosis of arteriovenous malformation was
considered, which was later confirmed on MRI. Her hemoglobin was 6 gm/dl, and it was
normochromic normocytic. Two pints of packed cells were transfused and selective uterine
artery embolization was performed. During this procedure, abnormal tortuous vessels arising
from branches of internal iliac arteries bilaterally and supplying the vascular malformation in
the uterus were super-selectively cannulated using the microcatheter technique. Embolization
was done using polyvinyl alcohol (PVA) particles of 335-1000 micron. Her bleeding stopped,
and she was discharged home in stable condition. Later on, she menstruated normally. She was
followed for 12 months during which she conceived spontaneously. Her pregnancy was low risk,
with good maternal and fetal outcomes.
FIGURE 1: Pelvic ultrasound showing dilated blood vessels
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Case 2 
A 37-year-old Asian woman, para five, all born by spontaneous vaginal delivery and one first
trimester miscarriage treated by dilatation and evacuation six months back, presented with
eight weeks missed miscarriage. Dilatation and evacuation were performed without any
complications. After 45 days, she reported in an emergency, with a single episode of profuse
and heavy vaginal bleeding and a history of irregular vaginal bleeding for the last 40 days. She
also took tab misoprostol 800 ug prescribed by a local practitioner in suspicion of retained
products of conception but the bleeding continued. There was no past history of a bleeding
disorder or a family history of any gynecologic cancer. On examination, she was in a state of
hemodynamic shock, with cold clammy skin, blood pressure 90/40 mmHg, and a weak, low-
volume pulse of 140/min. The chest was clear, with a respiratory rate of 20/min. Pelvic
examination showed a bulky uterus with closed os and normal adnexa. On investigations, her
hemoglobin was 5 gms/dl while platelets were normal. Red cell indices showed iron deficiency
anemia. Electrolytes, clotting profile, and renal function tests were normal. The histopathology
report of the previous evacuation revealed chorionic villi with no evidence of trophoblastic
disease. Her beta-human chorionic gonadotropin (HCG) was less than 25 IU/L. She was
resuscitated with two liters of intravenous (IV) normal saline. Bleeding was controlled with inj.
tranexamic acid 1 gm stat and then eight hourly. Four pints of packed cells were
transfused. Ultrasound Doppler was done, which showed a bulky uterus with irregular and
thickened endometrium with some debris and blood clots. Vascularity on color flow suspected
uterine arteriovenous malformation (Figure 2). She was planned for embolization but on
refusal, was managed conservatively on oral progesterone 5 mg three times for 21 days. She
remained asymptomatic for six months and had regular menstruation. Later, she opted for oral
contraceptive pills as she wanted to defer pregnancy.
FIGURE 2: Doppler ultrasound showing hypervascularity in the
endometrium
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Case 3
A 35-year-old lady, gravida 4 para 2+1, previous vaginal deliveries, and last miscarriage
followed by evacuation four months earlier was admitted with eight weeks missed miscarriage
for the evacuation of the uterus. After one month of the evacuation, she presented to a local
practitioner with heavy vaginal bleeding; evacuation was done again. The histopathology report
showed no trophoblastic disease. After five days of this procedure, the patient reported to us in
an emergency with heavy vaginal bleeding. On examination, she was hemodynamically stable
with an unremarkable systemic examination. Her complete blood pictures and clotting profile
was normal. Pelvic ultrasound was done, which showed a bulky uterus with mid-line thick
irregular endometrium suspecting retained products of conception (Figure 3).
FIGURE 3: Pelvic ultrasound showing thick endometrium
Color Doppler showed multiple blood vessels and a color mosaic pattern ( Figure 4). Her
selective uterine artery embolization was subsequently performed (Figure 5). She was followed
for 12 months, conceived spontaneously, had a low-risk pregnancy and delivered a healthy baby
vaginally at term.
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FIGURE 4: Doppler ultrasound showing increased vascularity
in the endometrium
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FIGURE 5: Selective uterine artery embolization
Case 4
A 38-year-old Asian woman, P5+1, all normal vaginal deliveries, presented with a history of
dilatation and evacuation under general anesthesia for seven weeks and missed miscarriage
two months back. Since the evacuation, she had multiple episodes of heavy vaginal bleeding,
which resolved spontaneously without taking any medication. In between these episodes, she
had mild irregular bleeding. On examination, she was afebrile and hemodynamically stable. Her
hemoglobin level was 12.0 g/dL, HCG level was less than 2 mIU/mL, which ruled out
trophoblastic disease. Pelvic examination revealed a normal-sized uterus and the os was closed
with minimal bleeding. Transabdominal ultrasound of the pelvis showed a bulky uterus, with
an endometrial thickness of 1.6 cm and increased vascularity of the uterus (Figure 6), which
was later confirmed by Doppler ultrasound. A provisional diagnosis of arteriovenous
malformation was considered, confirmed on MRI. Selective uterine artery embolization was
done. Follow-up after 15 days, four weeks, and 12 months was uneventful. She was put on
injectable progesterone as a method of contraception, as she did not desire pregnancy.
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FIGURE 6: Pelvic ultrasound with thick endometrium and
increased vascularity
Discussion
A uterine vascular abnormality is a rare but potentially life-threatening condition, which
usually presents with vaginal bleeding that can be profuse and cause hemodynamic instability
to the patient. It is considered an important differential in women of reproductive age with
unexplained vaginal bleeding, as well as in post-menopausal women when the ultrasound
reveals anechoic structures [15].
In 1926, the first case was reported by Dubreil and Loubart as a cricoid aneurism of the uterus
and since then, it had been referred to as an arteriovenous aneurysm or arteriovenous
malformations [16]. The true incidence is unknown, but with the increased use of ultrasound to
evaluate abnormal vaginal bleeding, Obrien et al. proposed a rough, predicted incidence of
4.5% of all genital and intraperitoneal hemorrhages [3]. They can be congenital or acquired [2].
Congenital lesions are rare while acquired lesions are due to previous uterine surgeries,
intrauterine devices, uterine infections, miscarriages, myomas, endometrial adenocarcinomas,
endometriosis, and trophoblastic diseases.
Arteriovenous malformations consist of abnormal growths and connections between arteries
and veins without a capillary bed, which are fragile and prone to bleed [17]. Congenital
arteriovenous malformations occur due to an abnormality in the embryological development of
primitive vascular structures, resulting in multiple abnormal communications between arteries
and veins that invade the surrounding structures while the acquired results from trauma thus
remain confined within the myometrium or endometrium, showing direct communication
between the intramural branches of the uterine arteries and myometrial veins [18]. This is the
basic difference between congenital and acquired forms.
The common presentation of arteriovenous malformation is usually in women of reproductive
age, with a previous history of uterine surgery or procedures and vaginal bleeding, which may
be intermittent or abundant, leading to hemodynamic instability as seen in three of our cases.
Sometimes, pelvic pain is associated with vaginal bleeding [17]. Clinical examination can be
unremarkable or with heavy vaginal bleeding [19]. Our reported case series presented the same
classical pictures, i.e. women of reproductive age, a previous history of procedures, i.e.
dilatation and evacuation with profuse vaginal bleeding, while one of them was in a state of
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shock.
An arteriovenous malformation is diagnosed initially with pelvic ultrasonography, in which it
appears as a mass with multiple hypo/anechoic tubular structures of multiple sizes. Focal
endometrial and myometrial thickenings can also be diagnostic. Doppler ultrasound adds the
possibility of recognizing vessels within the malformations [18]. The confirmation is done with
MRI or angiography. The typical MRI finding is a bulky uterus, with the presence of serpiginous
and dilated vessels within the myometrium or parametrium [2,17]. Convention angiography,
being the gold standard technique, shows enlarged, dilated irregular vascular spaces supplied
by enlarged uterine arteries with high-flow dynamics [18]. Serum beta-HCG is recommended to
exclude a gestational trophoblastic disease [18]. In our reported cases, first, a pelvis ultrasound
was done, followed by Doppler, which further added to the possibility, and it was finally
confirmed by MRI.
In the differential diagnosis, two conditions, i.e. retained products of conception and
gestational trophoblastic disease, are important; they should be ruled out before final
diagnosis. The gestational trophoblastic disease was ruled out in our four cases by confirming
the histopathology report of retained products of conception and serum beta-HCG.
There is no clear consensus in the literature on the best treatment option for the disease. The
current conservative medical or surgical options are based on the clinician’s expertise and a
conclusion drawn from published case reports. The definitive treatment of arteriovenous
malformation consists of surgical hysterectomy whereas conservative treatment is selective
uterine arterial embolization [4,10,18]. The preferred treatment is selective uterine artery
embolization in women of reproductive age who have a desire to conserve future fertility [4].
The definite surgical treatment, i.e. hysterectomy is reserved for those cases in which
embolization is not feasible or contraindicated [2]. Three of our cases were managed by
embolization successfully, with future fertility, as two of them had a live birth later on.
Another recently reported approach is the hysteroscopic resection of the uterine lesion by
Stefano et al., from Italy [8], whereby 11 cases of arteriovenous malformations were managed
successfully by operative hysteroscopy and four of them achieved a pregnancy that carried to
term. The median duration of hysteroscopy was 30 minutes. This novel approach can be a
breakthrough in the management of uterine arteriovenous malformations, as the author
reported a 100% success rate with no surgical complications, high fertility outcomes, and short
hospital stay. Further studies are required from other parts of the world to declare it as the
standard treatment.
The conservative approach, i.e. medical treatment with combined oral contraceptive pills and
progestogens is reported in some case reports for asymptomatic patients or with mild
hemorrhage [20]. One of our cases was managed on hormones, although she was
hemodynamically unstable, her bleeding stopped after injection tranexamic acid, and once she
was stable, she was started on oral progesterone for 21 days and remained stable thereafter.
All patients remained stable through the diagnostic journey and had no morbidity and
mortality. They were all appropriately diagnosed and managed. The prognosis after treatment
was excellent and all patients were satisfied, which is one of the strengths. However, our
limitation was the small sample size, as we report only four cases over a period of three years.
We need more cases to see the diversity of the clinical presentation of the disease. The
prognosis after treatment was excellent, and future fertility was conserved.
This case series highlights the importance of considering an arteriovenous malformation in a
patient of childbearing age with heavy vaginal bleeding after a uterine procedure, the use of
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pelvic ultrasound, Doppler ultrasound, and MRI to confirm the diagnosis of arteriovenous
malformation without any delay and to take a quick decision to perform selective uterine artery
embolization to save her from life-threatening uterine bleeding and to retain her future
fertility.
Conclusions
Arteriovenous malformations are rare and dangerous clinical entities. Uterine bleeding, being
one of the most common presenting complaints in women, can be life-threatening in specific
situations. In a patient presenting with sudden and heavy vaginal bleeding, along with a history
of prior uterine instrumentation, the possibility of uterine arteriovenous malformation should
always be explored. Their management is complicated and challenging, requiring a high index
of suspicion. Color or spectral Doppler ultrasonography are the best diagnostic tools that
provide the most accurate information for confirmation. Hysteroscopy is an upcoming
diagnostic and treatment modality. A clear understanding of the disease, a high index of
suspicion, and the use of diagnostic modalities will bring a comprehensive clinical impact in
the treatment of such difficult cases.
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